Log in
Enquire now
‌

US Patent 11911348 Therapeutic agent for cancer

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119113480
Patent Inventor Names
Tomonori Yaguchi0
Yutaka Kawakami0
Taeko Hayakawa0
Atsushi Imaizumi0
Date of Patent
February 27, 2024
0
Patent Application Number
170667440
Date Filed
October 9, 2020
0
Patent Citations
‌
US Patent 10421807 Interleukin-31 monoclonal antibody
0
‌
US Patent 11787864 Heterodimeric Fc-fused proteins
0
‌
US Patent 9334331 Bispecific antibodies
0
‌
US Patent 11692042 Anti-CD73 antibodies and methods of use thereof
0
Patent Primary Examiner
‌
Lynn A Bristol
0
CPC Code
‌
A61K 31/12
0
‌
A61K 39/39558
0
Patent abstract

To provide a therapeutic agent for cancer having a higher therapeutic effect. A therapeutic agent for cancer, containing: at least one selected from the group consisting of curcumin and a derivative thereof; and at least one selected from the group consisting of an anti-PD-1 antibody, an anti-PD-L1 antibody, and an anti-PD-L2 antibody in combination.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 11911348 Therapeutic agent for cancer

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.